The role of hepcidin in early diagnostic of atherosclerosis in OSA

V. Pencheva Genova (Sofia, Bulgaria), V. Manolov (Sofia, Bulgaria), O. Georgiev (Sofia, Bulgaria), V. Vasilev (Sofia, Bulgaria), R. Emilova (Sofia, Bulgaria), I. Petrova (Sofia, Bulgaria), S. Hadjidekova (Sofia, Bulgaria), M. Karadjova (Sofia, Bulgaria), M. Nikolova (Sofia, Bulgaria), G. Angov (Sofia, Bulgaria), I. Petrova-Ivanova (Sofia, Bulgaria), T. Kunchev (Sofia, Bulgaria), K. Tzatchev (Sofia, Bulgaria), L. Traykov (Sofia, Bulgaria)

Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Pencheva Genova (Sofia, Bulgaria), V. Manolov (Sofia, Bulgaria), O. Georgiev (Sofia, Bulgaria), V. Vasilev (Sofia, Bulgaria), R. Emilova (Sofia, Bulgaria), I. Petrova (Sofia, Bulgaria), S. Hadjidekova (Sofia, Bulgaria), M. Karadjova (Sofia, Bulgaria), M. Nikolova (Sofia, Bulgaria), G. Angov (Sofia, Bulgaria), I. Petrova-Ivanova (Sofia, Bulgaria), T. Kunchev (Sofia, Bulgaria), K. Tzatchev (Sofia, Bulgaria), L. Traykov (Sofia, Bulgaria). The role of hepcidin in early diagnostic of atherosclerosis in OSA. 2521

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of screening in early diagnosis of COPD
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010


The role of biomarkers in the management of severe asthma
Source: International Congress 2019 – Severe asthma guidelines: update 2019
Year: 2019


Is OSA an important risk factor for metabolic dysregulation in obese COPD patients
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


How can identified early presence of atherosclerotic plaque in severe OSAS?
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011

The subclinical atherosclerosis and its association to clinical features of stable COPD
Source: Annual Congress 2011 - COPD management
Year: 2011

The role of obesity in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019


Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma
Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019
Year: 2020



The role of Hs-CRP in evaluating asthma severity and asthma control
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010

Investigation of possible role of serum fibulin as biomarker of COPD.
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


The role of airways 17ß-estradiol as a biomarker of severity in post-menopausal asthma
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020


The role of obesity
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Clinical parameters and biomarkers for the early detection of impaired glucose tolerance in OSA patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012


Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target
Source: Eur Respir Rev, 29 (155) 190102; 10.1183/16000617.0102-2019
Year: 2020



The role of leptin and adiponectin in patients with COPD
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


The role of biomarkers and effectiveness of maintenance therapy in stable severe COPD
Source: International Congress 2017 – COPD management
Year: 2017

Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD
Source: Eur Respir J 2014; 43: 951-953
Year: 2014


Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012


Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease?
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011